DTRT Health Acquisition Corp. Class A Common Stock
DTRT
DTRT was delisted on the 1st of February, 2023.
0 hedge funds and large institutions have $0 invested in DTRT Health Acquisition Corp. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.
100% less funds holding
Funds holding: 17 → 0 (-17)
100% less capital invested
Capital invested by funds: $30.3M → $0 (-$30.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 17
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$5.53M |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
-$3.34M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$3.11M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.59M |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$2.38M |
DTRT Hedge Fund Activity: Q1 2023 in Review
0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in DTRT Health Acquisition Corp. Class A Common Stock (DTRT) for Q1 2023, worth a combined $0 — down 100% from $30.3M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of DTRT and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Meteora Capital, exiting entirely with an estimated $5.53M sold.
- 0 institutional investors held DTRT Health Acquisition Corp. Class A Common Stock (DTRT) as of Q1 2023, down from 17 in Q4 2022.
- Funds reported $0 of DTRT Health Acquisition Corp. Class A Common Stock stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new DTRT Health Acquisition Corp. Class A Common Stock positions in Q1 2023 and 17 closed out, a net change of -17 holders.
- The largest DTRT Health Acquisition Corp. Class A Common Stock seller in Q1 2023 was Meteora Capital, an estimated $5.53M sold.
Based on aggregated 13F filings for Q1 2023.